LogicBio Therapeutics (LOGC) Misses Q2 EPS by 50c

August 8, 2024 6:10 PM

LogicBio Therapeutics (NASDAQ: LOGC) reported Q2 EPS of ($0.50).

For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.